DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Viread (Tenofovir Disoproxil) - Reports of Side Effects & Adverse Reactions

 



This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Viread (Tenofovir Disoproxil). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.

Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.

All cases (246)
     Renal Failure Acute (32)Abortion Spontaneous (18)Lactic Acidosis (16)more >>

Cases resulting in a serious event (244)
     Renal Failure Acute (32)Abortion Spontaneous (18)Lactic Acidosis (16)more >>

Cases resulting in death (26)
     Renal Failure Acute (13)Lactic Acidosis (12)Vomiting (5)more >>

Cases resulting in life threatening events (18)
     Renal Failure Acute (8)Renal Failure (4)Pancreatitis Acute (3)more >>

Cases resulting in hospitalization (107)
     Renal Failure Acute (20)Renal Failure (14)Vomiting (12)more >>

Cases resulting in disability (21)
     Renal Failure (4)Renal Impairment (4)Optic Neuritis Retrobulbar (3)more >>

Cases resulting in other serious reactions (109)
     Abortion Spontaneous (18)Beta 2 Microglobulin Urine Increased (7)Stillbirth (7)more >>

Below is a sample of reports where side effects / adverse reactions may be related to Viread (Tenofovir Disoproxil). For a complete list and/or a specific selection of reports, please use the links in the index above.

Adverse event in receiving Viread (Tenofovir Disoproxil)

Reported by a individual with unspecified qualification from Italy on 2007-10-30

Patient:

Adverse reactions / side effects: Beta 2 Microglobulin Urine Increased

Suspect drug(s):
Viread (Tenofovir Disoproxil)



Adverse event in receiving Viread (Tenofovir Disoproxil)

Reported by a individual with unspecified qualification from Italy on 2007-10-30

Patient:

Adverse reactions / side effects: Beta 2 Microglobulin Urine Increased

Suspect drug(s):
Viread (Tenofovir Disoproxil)



Adverse event in receiving Viread (Tenofovir Disoproxil)

Reported by a individual with unspecified qualification from Italy on 2007-10-30

Patient:

Adverse reactions / side effects: Beta 2 Microglobulin Urine Increased

Suspect drug(s):
Viread (Tenofovir Disoproxil)



Adverse event in receiving Viread (Tenofovir Disoproxil)

Reported by a individual with unspecified qualification from Italy on 2007-10-30

Patient:

Adverse reactions / side effects: Beta 2 Microglobulin Urine Increased

Suspect drug(s):
Viread (Tenofovir Disoproxil)



Adverse event in receiving Viread (Tenofovir Disoproxil)

Reported by a individual with unspecified qualification from Italy on 2007-10-30

Patient:

Adverse reactions / side effects: Beta 2 Microglobulin Urine Increased

Suspect drug(s):
Viread (Tenofovir Disoproxil)



Adverse event in receiving Viread (Tenofovir Disoproxil)

Reported by a individual with unspecified qualification from Italy on 2007-10-30

Patient:

Adverse reactions / side effects: Beta 2 Microglobulin Urine Increased

Suspect drug(s):
Viread (Tenofovir Disoproxil)



Adverse event in receiving Viread (Tenofovir Disoproxil)

Reported by a individual with unspecified qualification from Italy on 2007-10-30

Patient:

Adverse reactions / side effects: Beta 2 Microglobulin Urine Increased

Suspect drug(s):
Viread (Tenofovir Disoproxil)



Adverse event in male receiving Viread (Tenofovir Disoproxil)

Reported by a physician from United Kingdom on 2007-10-29

Patient: male, weighing 73.0 kg (160.6 pounds)

Adverse reactions / side effects: Weight Decreased, Abdominal Pain, Fanconi Syndrome Acquired, Blood Chloride Increased, Polyuria, Acidosis, Thirst, Blood Phosphorus Decreased, Malaise, Glycosuria, Proteinuria, Blood Bicarbonate Increased, Blood Creatinine Increased

Suspect drug(s):
Viread (Tenofovir Disoproxil)

Other drugs received by patient: Didanosine; Kaletra; CO-Trimoxazole



Adverse event in 51 year old male receiving Viread (Tenofovir Disoproxil)

Reported by a physician from Thailand on 2007-10-26

Patient: 51 year old male, weighing 55.0 kg (121.0 pounds)

Adverse reactions / side effects: Renal Failure Acute

Adverse event resulted in: life threatening event

Suspect drug(s):
Viread (Tenofovir Disoproxil)

Other drugs received by patient: Lamivudine; Lopinavir and Ritonavir; Cotrimoxazole; Fluconazole; Ethambutol HCL; Azithromycin; Isoniazid; Ciprofloxacin; Prednisolone



Adverse event in 52 year old female receiving Viread (Tenofovir Disoproxil)

Reported by a physician from United Kingdom on 2007-10-24

Patient: 52 year old female

Adverse reactions / side effects: Overdose, Suicide Attempt

Suspect drug(s):
Viread (Tenofovir Disoproxil)



Adverse event in 24 year old male receiving Viread (Tenofovir Disoproxil)

Reported by a individual with unspecified qualification from United States on 2007-10-24

Patient: 24 year old male

Adverse reactions / side effects: Abdominal Pain, Weight Decreased, Gastrointestinal Motility Disorder, Hepatomegaly, Vomiting, Nausea, Gastritis

Suspect drug(s):
Viread

Etibi

Zithromax

Reyataz

Videx

Lamivudine

Kaletra

Bactrim



Adverse event in female receiving Viread (Tenofovir Disoproxil)

Reported by a physician from Sweden on 2007-10-23

Patient: female

Adverse reactions / side effects: Pregnancy, Ultrasound Antenatal Screen Abnormal

Suspect drug(s):
Viread (Tenofovir Disoproxil)

Other drugs received by patient: 3TC



Adverse event in male receiving Viread (Tenofovir Disoproxil)

Reported by a physician on 2007-10-23

Patient: male, weighing 89.0 kg (195.8 pounds)

Adverse reactions / side effects: Drug Resistance

Suspect drug(s):
Viramune
    Dosage: 200mg during 14 days, thereafter 400mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-05-21
    End date: 2007-07-30

Viread
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-05-21

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-05-21
    End date: 2007-07-30

Other drugs received by patient: Glucovance; Eusaprim; Eusaprim



Adverse event in male receiving Viread (Tenofovir Disoproxil)

Reported by a physician from Japan on 2007-10-22

Patient: male

Adverse reactions / side effects: Immune Reconstitution Syndrome, Cytomegalovirus Chorioretinitis, Bone Marrow Failure

Suspect drug(s):
Emtriva
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2006-01-01

Viread
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2006-01-01

Truvada
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2005-12-10
    End date: 2006-01-01

Other drugs received by patient: Efavirenz



Adverse event in 50 year old male receiving Viread (Tenofovir Disoproxil)

Reported by a health professional (non-physician/pharmacist) from France on 2007-10-22

Patient: 50 year old male

Adverse reactions / side effects: Blood Folate Decreased, Back Pain, Pain in Extremity, Fanconi Syndrome Acquired, Muscular Weakness, Extrapyramidal Disorder, Osteomalacia, Nerve Conduction Studies Abnormal

Adverse event resulted in: hospitalization

Suspect drug(s):
Viread (Tenofovir Disoproxil)

Other drugs received by patient: Epivir; Viracept; Depakine 500



Adverse event in 71 year old male receiving Viread (Tenofovir Disoproxil)

Reported by a health professional (non-physician/pharmacist) from France on 2007-10-22

Patient: 71 year old male, weighing 53.0 kg (116.6 pounds)

Adverse reactions / side effects: Neuropathy, Renal Tubular Disorder, Vitamin D Deficiency, Blood Parathyroid Hormone Increased

Suspect drug(s):
Sustiva
    Start date: 2002-03-01

Zerit

Videx

Kaletra
    Start date: 2002-03-01

Viread
    Start date: 2002-03-01

Plaquenil

Other drugs received by patient: Virlix; Tenormin; Corvasal; Aspegic 325; Omeprazole



Adverse event in male receiving Viread (Tenofovir Disoproxil)

Reported by a health professional (non-physician/pharmacist) from France on 2007-10-22

Patient: male, weighing 53.0 kg (116.6 pounds)

Adverse reactions / side effects: Hypophosphataemia, Vitamin D Deficiency, Bone Pain, Pain

Adverse event resulted in: hospitalization

Suspect drug(s):
Viread
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-03-01

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-03-01

Sustiva
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-03-01

Plaquenil

Other drugs received by patient: Virlix; Tenormin; Corvasal; Aspegic 325



Adverse event in 24 year old male receiving Viread (Tenofovir Disoproxil)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-19

Patient: 24 year old male

Adverse reactions / side effects: Abdominal Pain, Weight Decreased, Hepatomegaly, Lymphadenopathy, Bacterial Infection, Gastritis, Ileus Paralytic

Suspect drug(s):
Reyataz
    Administration route: Oral

Videx

Etibi

Lamivudine

Kaletra

Viread

Zithromax

Bactrim



Adverse event in 24 year old male receiving Viread (Tenofovir Disoproxil)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-18

Patient: 24 year old male

Adverse reactions / side effects: Abdominal Pain, Weight Decreased, Hepatomegaly, Lymphadenopathy, Bacterial Infection, Gastritis, Ileus Paralytic

Suspect drug(s):
Zithromax
    Dosage: daily dose:600mg-freq:frequency: qd

Etibi
    Dosage: daily dose:800mg-freq:frequency: qd

Kaletra
    Dosage: text:3 df-freq:frequency: bid

Reyataz
    Dosage: daily dose:300mg-freq:frequency: qd
    Administration route: Oral

Lamivudine
    Dosage: daily dose:150mg-freq:frequency: bid

Viread
    Dosage: daily dose:300mg-freq:frequency: qd

Bactrim
    Dosage: text:1 df-freq:frequency: qd

Videx
    Dosage: daily dose:250mg-freq:frequency: qd



Adverse event in male receiving Viread (Tenofovir Disoproxil)

Reported by a health professional (non-physician/pharmacist) from France on 2007-10-16

Patient: male, weighing 53.0 kg (116.6 pounds)

Adverse reactions / side effects: Hypophosphataemia, Vitamin D Deficiency, Pain in Extremity, Pain

Adverse event resulted in: hospitalization

Suspect drug(s):
Sustiva
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-03-01

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-03-01

Viread
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-03-01

Plaquenil
    Dosage: unk
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Other drugs received by patient: Aspegic 325; Corvasal; Tenormin; Virlix; Omeprazole



Adverse event in 43 year old male receiving Viread (Tenofovir Disoproxil)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-16

Patient: 43 year old male

Adverse reactions / side effects: Immune Reconstitution Syndrome, Cytomegalovirus Chorioretinitis, Bone Marrow Failure

Adverse event resulted in: hospitalization

Suspect drug(s):
Stocrin Caps
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2005-12-10

Baktar
    Administration route: Oral
    Indication: Pneumocystis Jiroveci Pneumonia
    Start date: 2006-01-01

Viread
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2006-01-01

Emtriva
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2006-01-01

Valixa
    Administration route: Oral
    Indication: Cytomegalovirus Chorioretinitis
    Start date: 2006-01-17

Truvada
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2005-12-10
    End date: 2006-01-01

Rabeprazole Sodium
    Administration route: Oral
    Indication: Adverse Drug Reaction
    Start date: 2005-12-01

Gasmotin
    Administration route: Oral
    Indication: Adverse Drug Reaction
    Start date: 2006-01-01



Adverse event in 24 year old male receiving Viread (Tenofovir Disoproxil)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-15

Patient: 24 year old male

Adverse reactions / side effects: Abdominal Pain, Weight Decreased, Gastrointestinal Motility Disorder, Hepatomegaly, Vomiting, Nausea, Gastritis

Suspect drug(s):
Zithromax
    Dosage: daily dose:600mg

Etibi
    Dosage: daily dose:800mg

Reyataz
    Dosage: daily dose:300mg

Videx
    Dosage: daily dose:250mg

Lamivudine

Viread

Kaletra

Bactrim



Adverse event in 52 year old male receiving Viread (Tenofovir Disoproxil)

Reported by a physician from France on 2007-10-15

Patient: 52 year old male

Adverse reactions / side effects: Optic Neuritis Retrobulbar

Adverse event resulted in: disablity

Suspect drug(s):
Invirase
    Dosage: reported dosing amount: 4 doses daily.
    Start date: 2006-06-23

Invirase
    Start date: 2002-03-18

Bactrim DS
    Dosage: also received on 28 september 2005 and 23 june 2006.
    Indication: Drug USE FOR Unknown Indication
    Start date: 1998-10-27

Combivir
    Dosage: reported dosing amount: 2 doses daily.
    Start date: 2005-09-28
    End date: 2006-06-23

Combivir
    Start date: 1999-05-11
    End date: 1999-08-01

Combivir
    Start date: 2001-03-23

Telzir
    Dosage: reported dosing amount: 2 doses daily. also received on 17 june 2005.
    Start date: 2005-03-29
    End date: 2006-06-23

Norvir
    Dosage: also received on 15 october 2004, 29 march 2005, 28 september 2005, 17 june 2005 and 23 june 2006.
    Start date: 2004-04-17

Norvir
    Start date: 1999-09-21

Norvir
    Start date: 2000-06-06

Norvir
    Start date: 2001-03-23

Norvir
    Start date: 2002-03-18

Neurontin
    Indication: Trigeminal Neuralgia
    Start date: 2006-01-01

Lyrica
    Indication: Trigeminal Neuralgia
    Start date: 2006-06-23

Retrovir
    Indication: Drug USE FOR Unknown Indication
    Start date: 2006-06-23

Retrovir
    Start date: 2005-06-17

Viread
    Indication: Drug USE FOR Unknown Indication
    Start date: 2006-06-23

Viread
    Start date: 2003-01-03

Viread
    Start date: 2003-09-12

Viread
    Start date: 2004-04-17

Viread
    Start date: 2004-10-15

Viread
    Start date: 2005-03-29

Viread
    Start date: 2005-06-17

Other drugs received by patient: Sustiva; Videx; Videx; Videx; Zerit; Zerit; Zerit; Zerit; Hivid; Hivid; Crixivan; Crixivan; 1 Concomitant Drug; Epivir; Agenerase; Kaletra; Kaletra; Fuzeon; Fuzeon; 1 Concomitant Drug; 1 Concomitant Drug; Ziagen; Tercian; Laroxyl; Tenofovir



Adverse event in male receiving Viread (Tenofovir Disoproxil)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-15

Patient: male

Adverse reactions / side effects: Abdominal Hernia, Cardiac Murmur, Cryptorchism, Abdominal Distension

Suspect drug(s):
Viread
    Indication: HIV Infection
    Start date: 2004-06-01
    End date: 2004-07-20

Combivir
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2004-06-01

Viracept
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2004-07-20

Kaletra
    Indication: HIV Infection
    Start date: 2004-06-01

Retrovir
    Indication: HIV Infection
    Start date: 2004-06-01
    End date: 2004-07-20

Other drugs received by patient: Folic Acid



Adverse event in female receiving Viread (Tenofovir Disoproxil)

Reported by a physician from United States on 2007-10-15

Patient: female, weighing 20.0 kg (44.0 pounds)

Adverse reactions / side effects: Weight Decreased, Fanconi Syndrome, Hyperglycaemia, Nephrogenic Diabetes Insipidus

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Viread
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-01-01
    End date: 2007-09-12

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-01-01
    End date: 2007-09-12

DDI
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-01-01
    End date: 2007-09-12

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009